Refractory warts: topical or intralesional cidofovir options

Published Date: 02 Mar 2023

New research suggests that cidofovir may be a helpful option for tender joints or joints.

Read Full News

Latest News

Early Intensive Therapy Best for PsA With Poor Prognosis

Early intensive treatment for PsA with csDMARDs or 6 months of TNFi is superior to standard step-up care, and better outcomes were maintained at 48 weeks in the TNFi group.

Guselkumab Effective After TNF Inhibitor Failure in PsA

Guselkumab, administered every 4 or 8 weeks, is effective and safe in patients with active psoriatic arthritis who have had an inadequate response to only one prior TNF inhibitor.

Meta-analysis: Dermoscopic Features Distinguish ALM

Parallel ridge and multicomponent patterns are the most common dermoscopic features that identify acral lentiginous melanoma, according to a meta-analysis.

Geriatric Oncology Has Become Personalized: Here’s Why

As immunotherapy reshaped cancer care, geriatric oncology shifted toward personalized, geriatric assessment-guided treatment that prioritizes function, safety, and what matters most to older adults.

Hidradenitis Suppurativa Raises Risk for Self-Harm, Suicide

Patients with hidradenitis suppurativa have a higher risk for self-harm and suicide than matched control individuals, according to the results of a Danish cohort study.

Perianal Abscess Tied to Crohn's Disease Risk in Older Kids

Older children with perianal abscess or fistula-in-ano, especially those with recurrent perianal abscess or fistula-in-ano or gastrointestinal symptoms, are more likely to develop Crohn's disease.

Todays Updates

Winter Sports and Lower Limb Motor Disability

People with lower limb motor disability need tailored equipment, training, and medical oversight to boost performance while preventing upper limb overload and skin problems.

Can Better Screening Prevent Maternal VTE Deaths?

Nearly half of maternal deaths from venous thromboembolism in France over 12 years were preventable.

'Concerning': CRC Continues to Shift Toward Younger Adults

Nearly half of new colorectal cancer cases now occur in people younger than age 65 years, highlighting the need for earlier screening and better symptom awareness.

Tight Glycemic Target in Gestational Diabetes Reduces Risks

Tight glycemic targets in gestational diabetes can lower the risk for large-for-gestational-age births without increasing the risk for serious maternal and neonatal complications.

Todays Updates

Winter Sports and Lower Limb Motor Disability

People with lower limb motor disability need tailored equipment, training, and medical oversight to boost performance while preventing upper limb overload and skin problems.

Can Better Screening Prevent Maternal VTE Deaths?

Nearly half of maternal deaths from venous thromboembolism in France over 12 years were preventable.

'Concerning': CRC Continues to Shift Toward Younger Adults

Nearly half of new colorectal cancer cases now occur in people younger than age 65 years, highlighting the need for earlier screening and better symptom awareness.

Tight Glycemic Target in Gestational Diabetes Reduces Risks

Tight glycemic targets in gestational diabetes can lower the risk for large-for-gestational-age births without increasing the risk for serious maternal and neonatal complications.

Latest News

Early intensive treatment for PsA with csDMARDs or 6 months of TNFi is superior to standard step-up care, and better outcomes were maintained at 48 weeks in the TNFi group.

Guselkumab, administered every 4 or 8 weeks, is effective and safe in patients with active psoriatic arthritis who have had an inadequate response to only one prior TNF inhibitor.

Parallel ridge and multicomponent patterns are the most common dermoscopic features that identify acral lentiginous melanoma, according to a meta-analysis.

As immunotherapy reshaped cancer care, geriatric oncology shifted toward personalized, geriatric assessment-guided treatment that prioritizes function, safety, and what matters most to older adults.

Patients with hidradenitis suppurativa have a higher risk for self-harm and suicide than matched control individuals, according to the results of a Danish cohort study.

Older children with perianal abscess or fistula-in-ano, especially those with recurrent perianal abscess or fistula-in-ano or gastrointestinal symptoms, are more likely to develop Crohn's disease.

News All Time

Expert Meeting on US Measles Elimination Status Delayed to November

A meeting of an international panel of experts that was set to review the United States' measles ⁠elimination status next month has been postponed until November, the Pan...

Melanoma Cases Top Skin Cancer Lawsuits

A review finds melanoma accounts for nearly half of skin cancer malpractice cases, with delayed diagnosis being the leading allegation.

CSF Biomarkers Suggest Impact of Herpes on Brain Health

Biomarkers for Alzheimer’s disease are linked to latent infection in people with HIV.

MHRA Clears Brensocatib for Bronchiectasis

The MHRA has licensed brensocatib as the first disease-specific therapy for non-cystic fibrosis bronchiectasis in patients with recurrent exacerbations.

Bimekizumab Improves Hidradenitis Suppurativa Severity

Bimekizumab yields clinically meaningful improvements in the severity of hidradenitis suppurativa over 48 weeks, shifting most patients to a mild disease, a pooled analysis of two trials shows.

Americans Trust Vaccines, School Mandates, Rejecting Trump Agenda, Reuters/Ipsos Poll Finds

A bipartisan majority of Americans believe vaccines are safe and that children should receive them to attend school, according to a new Reuters/Ipsos poll, illustrating the...

New Mental Health Disorders Tied to Early Cancer Mortality

In a decade-long analysis of University of California health system data, researchers assess early-onset mental health disorders after cancer diagnosis and subsequent survival trends.

NHS to Fund Ruxolitinib for Vitiligo

NICE has recommended topical ruxolitinib for facial non-segmental vitiligo in patients aged 12 or over after a revised cost review.

Lipedema Is Now Recognized as a Chronic Disease

International consensus defines lipedema as a chronic disease; clarifies its biology and diagnosis; and urges standardized care, research, and policy action.

Lilly's Zepbound and Taltz Improve Psoriasis Symptoms, Drive Weight Loss in Study

Eli Lilly said on Wednesday its weight-loss drug, Zepbound, used with psoriasis treatment Taltz, showed ⁠better results in patients with the skin disease and obesity in a...

Bimekizumab Eases Plaque Psoriasis Symptoms Up to 3 Years

Patients with moderate‑to‑severe plaque psoriasis achieve greater relief from itching, skin pain, and scaling with bimekizumab vs secukinumab up to 3 years.

Amivantamab Tied to Diverse Dermatologic Events in NSCLC

Treatment with amivantamab is associated with a broad spectrum of dermatologic adverse events that can be severe in patients with non-small cell lung cancer, a real-world study shows.

Exploring Cutting-Edge Data for New and Emerging Treatments in Chronic Spontaneous Urticaria

Exploring Cutting-Edge Data for New and Emerging Treatments in Chronic Spontaneous Urticaria

Ask the Experts: The Latest Updates in the Pathophysiology and Targeted Treatment of Chronic Spontaneous Urticaria

Ask the Experts: The Latest Updates in the Pathophysiology and Targeted Treatment of Chronic Spontaneous Urticaria

Navigating Chronic Spontaneous Urticaria Diagnosis, Assessment, and Treatment Selection

Navigating Chronic Spontaneous Urticaria Diagnosis, Assessment, and Treatment Selection

Advancing Immune Checkpoint Inhibitor Use in Resectable Melanoma

Advancing Immune Checkpoint Inhibitor Use in Resectable Melanoma

Recommended News For You

While most cancer screenings won't prolong lives, there are still good reasons to continue screening.

Cancer mortality continuing to decline, says report

Alkem introduces cetuximab under the trade name Cetuxa in India.

Except for Black Patients, the Rates of Gallbladder Cancer Are Stable or Declining.

According to a study, patients with ovarian cancer who undergo aggressive surgery have a 70% lower chance of dying.

How a new light-based cancer treatment could destroy tumors without harming healthy cells—using LEDs

Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC

Recommended Articles For You

Late Effects of Immunotherapy in Chronic Melanoma Survivorship with Repurposed Drugs 

Understanding Blood Dyscrasia: Symptoms, Causes and Treatment Options 

Analyzing the Mechanisms and Efficacy of Carboplatin, Abraxane, and Albumin-Bound Formulations 

Cancer-Keeper Genes: Novel Therapeutic Targets for Disrupting Tumor Maintenance 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Limits to Anti-Nausea Pill Coverage Wear on Cancer Patients and Doctors

2.

Treating Depression: Crucial for Recovery From Fibromyalgia

3.

Hospitalization and mortality rates are associated with exposure to the omicron variant of COVID-19 in patients with solid cancer.

4.

Use of marijuana and alcohol simultaneously is associated with worse outcomes.

5.

Both DNA damage repair deficiency and non-Hodgkin lymphoma are the focus of LP-284.

1.

Ultrasound: A Promising Tool in the Fight Against Malignant Breast Cancer

2.

Radiation Oncology Advances: Guidelines, Trials, Digital Tools & Education

3.

Radioligand Therapy Advances: PSMA, Neuroendocrine, and Solid Tumor Clinical Insights

4.

The Silent Signs: Uncovering Stomach Cancer Symptoms Before It's Too Late

5.

Unlocking a New Era in Bladder Cancer Treatment: A Review of the TAR-200 Intravesical Drug Delivery System

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Thromboprophylaxis In Medical Settings

2.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

3.

Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC

4.

ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis

5.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot